Cargando…
The Strategies to Homogenize PET/CT Metrics: The Case of Onco-Haematological Clinical Trials
Positron emission tomography (PET) has been a widely used tool in oncology for staging lymphomas for a long time. Recently, several large clinical trials demonstrated its utility in therapy management during treatment, paving the way to personalized medicine. In doing so, the traditional way of repo...
Autores principales: | Chauvie, Stephane, Bergesio, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344268/ https://www.ncbi.nlm.nih.gov/pubmed/28536393 http://dx.doi.org/10.3390/biomedicines4040026 |
Ejemplares similares
-
Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease1
por: Hughes, Derralynn, et al.
Publicado: (2007) -
ADP-dependent glucokinase as a novel onco-target for haematological malignancies
por: Tandon, Amol, et al.
Publicado: (2020) -
Whole body MRI and PET/CT in haematological malignancies
por: Lin, Chieh, et al.
Publicado: (2007) -
Central venous catheter cannulation by a trained ultrasound team in onco-haematological patients
por: Soler, JA, et al.
Publicado: (2015) -
Vaccination coverage among paediatric onco-haematological patients: an Italian cross-sectional study
por: Giordano, Paola, et al.
Publicado: (2020)